Course of depressive symptomatology and its association with serum uric acid in one-anastomosis gastric bypass patients.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
27 10 2020
27 10 2020
Historique:
received:
20
01
2020
accepted:
13
10
2020
entrez:
28
10
2020
pubmed:
29
10
2020
medline:
11
3
2021
Statut:
epublish
Résumé
The changes in depressive symptomatology during the first year following one-anastomosis gastric bypass (OAGB) were evaluated and its association with uric acid (sUA). Fifty patients were included in this analysis. Beck Depression Inventory (BDI) for measuring depressive symptomatology, blood samples, and anthropometric measurements were assessed before (T0), at 6 (T6), and 12 months (T12) after surgery. There was a significant reduction in BDI total score at T6 (- 5.6 (95% CI - 2.1, - 9.1) points; p = 0.001) and at T12 (- 4.3 (95% CI - 0.9, - 7.9) points; p = 0.011). BMI loss was unrelated to depressive symptomatology. Patients with moderate to severe depressive symptomatology presented lower sUA levels than patients with none or minimal to mild (p = 0.028). ROC analysis revealed that sUA levels below 5.0 at T6 and 4.5 mg/dl at T12 had a prognostic accuracy for depression severity. Furthermore, delta sUA was significantly associated with delta BMI (β = 0.473; p = 0.012) and delta waist circumference (β = 0.531; p = 0.003). These findings support an improvement in depressive symptomatology in the first year postoperatively, however, without relation to BMI loss. Patients with moderate to severe depressive symptomatology presented with lower sUA levels over time. Therefore, sUA could be useful to predict moderate to severe depressive symptomatology in patients undergoing OAGB in clinical practice.
Identifiants
pubmed: 33110226
doi: 10.1038/s41598-020-75407-9
pii: 10.1038/s41598-020-75407-9
pmc: PMC7591541
doi:
Substances chimiques
Uric Acid
268B43MJ25
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
18405Références
Psychosom Med. 2016 Apr;78(3):373-81
pubmed: 26569540
Obes Surg. 2001 Jun;11(3):276-80
pubmed: 11433900
Curr Psychiatry Rep. 2013 Oct;15(10):397
pubmed: 23963631
J Psychosom Res. 2002 Mar;52(3):155-65
pubmed: 11897234
Obes Surg. 2015 Oct;25(10):1909-16
pubmed: 25720515
Indian J Clin Biochem. 2010 Jan;25(1):77-81
pubmed: 23105889
Trials. 2015 Aug 05;16:328
pubmed: 26242295
J Biol Regul Homeost Agents. 2013 Oct-Dec;27(4):981-8
pubmed: 24382179
Metabolism. 2014 Feb;63(2):242-9
pubmed: 24332707
J Affect Disord. 2015 Mar 15;174:464-6
pubmed: 25553407
Mod Rheumatol. 2020 Mar;30(2):385-390
pubmed: 30689484
Surg Obes Relat Dis. 2008 Sep-Oct;4(5):640-6
pubmed: 18586571
Surg Obes Relat Dis. 2006 Sep-Oct;2(5):549-60
pubmed: 17015211
Obes Surg. 2011 Mar;21(3):328-35
pubmed: 20559893
Curr Obes Rep. 2017 Mar;6(1):71-78
pubmed: 28243838
Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
Am J Psychiatry. 2007 Feb;164(2):328-34; quiz 374
pubmed: 17267797
Acta Anaesthesiol Scand. 1996 Aug;40(7):771-2
pubmed: 8874560
Obes Surg. 2017 May;27(5):1196-1207
pubmed: 27837387
Mol Psychiatry. 2018 Jan;23(1):94-106
pubmed: 28948971
Arch Gen Psychiatry. 2010 Mar;67(3):220-9
pubmed: 20194822
Obes Res Clin Pract. 2014 Jul-Aug;8(4):e299-313
pubmed: 25091351
Am J Psychiatry. 2009 Mar;166(3):285-91
pubmed: 19255051
Curr Opin Rheumatol. 2011 Mar;23(2):192-202
pubmed: 21285714
Psychoneuroendocrinology. 2015 Jan;51:164-75
pubmed: 25462890
J Affect Disord. 2018 Jan 1;225:684-690
pubmed: 28917195
PLoS One. 2015 Oct 07;10(10):e0138904
pubmed: 26445247
Obes Surg. 2018 Sep;28(9):2956-2967
pubmed: 29995293
J Clin Psychiatry. 2015 Dec;76(12):1658-67
pubmed: 26579881
Clin Biochem. 2012 Jan;45(1-2):49-53
pubmed: 22040815
Surg Obes Relat Dis. 2012 Jan-Feb;8(1):62-6
pubmed: 21256091
Curr Pharm Des. 2012;18(36):5890-9
pubmed: 22681168
Eur Arch Psychiatry Clin Neurosci. 2018 Mar;268(2):119-127
pubmed: 28620773
Br J Psychiatry. 2010 Jul;197(1):61-6
pubmed: 20592436
Obes Surg. 2010 Apr;20(4):426-31
pubmed: 18841428
Trials. 2010 Mar 24;11:32
pubmed: 20334632
Int J Obes (Lond). 2008 Sep;32(9):1431-7
pubmed: 18607383
Am J Surg. 2015 May;209(5):779-82
pubmed: 25952277
Surg Clin North Am. 2001 Oct;81(5):1001-24
pubmed: 11589242
Arch Intern Med. 2003 Sep 22;163(17):2058-65
pubmed: 14504119
Ann Surg. 2012 Dec;256(6):1023-9
pubmed: 22968072
Obes Surg. 2018 Nov;28(11):3492-3498
pubmed: 29984375
Stroke. 2006 Jun;37(6):1503-7
pubmed: 16675740
PLoS One. 2013 Oct 29;8(10):e76336
pubmed: 24204615
Surg Obes Relat Dis. 2008 Jul-Aug;4(4):544-9
pubmed: 18514586
J Clin Psychopharmacol. 2013 Aug;33(4):479-84
pubmed: 23771193
Clin Epidemiol. 2014 Jul 14;6:227-35
pubmed: 25053894
JAMA. 2004 Oct 13;292(14):1724-37
pubmed: 15479938
Obes Surg. 2007 Aug;17(8):1097-101
pubmed: 17953246
Neuropsychopharmacol Hung. 2012 Dec;14(4):231-8
pubmed: 23269209
JAMA Surg. 2014 Mar;149(3):275-87
pubmed: 24352617
Surg Obes Relat Dis. 2010 Mar 4;6(2):191-6
pubmed: 20189470
Obesity (Silver Spring). 2013 Mar;21 Suppl 1:S1-27
pubmed: 23529939
J Affect Disord. 2014 Aug;165:131-4
pubmed: 24882190
Psychosom Med. 2014 Jan;76(1):12-9
pubmed: 24336428
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Aug 30;94:109651
pubmed: 31095994
Surg Obes Relat Dis. 2015 May-Jun;11(3):637-42
pubmed: 25863536
J Intern Med. 2008 Dec;264(6):599-609
pubmed: 18793245
Int J Obes Relat Metab Disord. 2003 Nov;27(11):1300-14
pubmed: 14574339
Obes Surg. 2010 Apr;20(4):432-9
pubmed: 19760466
J Affect Disord. 2017 Jan 15;208:56-61
pubmed: 27750060
Am J Surg. 2010 Feb;199(2):183-8
pubmed: 19362287
Diabetes Care. 2011 May;34 Suppl 2:S355-60
pubmed: 21525482
Eat Weight Disord. 2020 Apr;25(2):283-289
pubmed: 30264389
Compr Psychiatry. 2003 Sep-Oct;44(5):428-34
pubmed: 14505305
Obesity (Silver Spring). 2014 Aug;22(8):1799-806
pubmed: 24634371
JAMA. 2003 Jun 18;289(23):3095-105
pubmed: 12813115
J Postgrad Med. 2019 Apr-Jun;65(2):74-80
pubmed: 29943744
Am J Epidemiol. 2000 Jul 15;152(2):163-70
pubmed: 10909953